Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa.

Caruso MP, Falivene J, Holgado MP, Zurita DH, Laufer N, Castro C, Nico Á, Maeto C, Salido J, Pérez H, Salomón H, Cahn P, Sued O, Fink V, Turk G, Gherardi MM.

Sci Rep. 2019 Feb 13;9(1):1978. doi: 10.1038/s41598-019-38547-1.

2.

Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection.

Salido J, Ruiz MJ, Trifone C, Figueroa MI, Caruso MP, Gherardi MM, Sued O, Salomón H, Laufer N, Ghiglione Y, Turk G.

Front Immunol. 2018 Oct 23;9:2443. doi: 10.3389/fimmu.2018.02443. eCollection 2018.

3.

Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?

Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, Trifone C, Ruiz MJ, Falivene J, Holgado MP, Caruso MP, Figueroa MI, Salomón H, Giavedoni LD, Pando MLÁ, Gherardi MM, Rabinovich RD, Pury PA, Sued O.

Viruses. 2018 Jan 13;10(1). pii: E34. doi: 10.3390/v10010034.

4.

Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.

Ruiz MJ, Salido J, Abusamra L, Ghiglione Y, Cevallos C, Damilano G, Rodriguez AM, Trifone C, Laufer N, Giavedoni LD, Sued O, Salomón H, Gherardi MM, Turk G.

EBioMedicine. 2017 Dec;26:25-37. doi: 10.1016/j.ebiom.2017.11.001. Epub 2017 Nov 3.

5.

Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses.

Holgado MP, Falivene J, Maeto C, Amigo M, Pascutti MF, Vecchione MB, Bruttomesso A, Calamante G, Del Médico-Zajac MP, Gherardi MM.

Viruses. 2016 May 23;8(5). pii: E139. doi: 10.3390/v8050139.

6.

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Ruiz MJ, Ghiglione Y, Falivene J, Laufer N, Holgado MP, Socías ME, Cahn P, Sued O, Giavedoni L, Salomón H, Gherardi MM, Rodríguez AM, Turk G.

J Virol. 2016 Jan 15;90(2):670-81. doi: 10.1128/JVI.02363-15. Print 2016 Jan 15.

7.

A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.

Peña D, Rovetta AI, Hernández Del Pino RE, Amiano NO, Pasquinelli V, Pellegrini JM, Tateosian NL, Rolandelli A, Gutierrez M, Musella RM, Palmero DJ, Gherardi MM, Iovanna J, Chuluyan HE, García VE.

EBioMedicine. 2015 May 30;2(8):884-90. doi: 10.1016/j.ebiom.2015.05.026. eCollection 2015 Aug.

8.

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression.

Falivene J, Ghiglione Y, Laufer N, Socías ME, Holgado MP, Ruiz MJ, Maeto C, Figueroa MI, Giavedoni LD, Cahn P, Salomón H, Sued O, Turk G, Gherardi MM.

Sci Rep. 2015 Jun 23;5:11511. doi: 10.1038/srep11511.

9.

Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.

Maeto C, Rodríguez AM, Holgado MP, Falivene J, Gherardi MM.

PLoS One. 2014 Sep 12;9(9):e107524. doi: 10.1371/journal.pone.0107524. eCollection 2014.

10.

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.

Ghiglione Y, Falivene J, Ruiz MJ, Laufer N, Socías ME, Cahn P, Giavedoni L, Sued O, Gherardi MM, Salomón H, Turk G.

PLoS One. 2014 Aug 5;9(8):e104235. doi: 10.1371/journal.pone.0104235. eCollection 2014.

11.

Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Turk G, Ghiglione Y, Falivene J, Socias ME, Laufer N, Coloccini RS, Rodriguez AM, Ruiz MJ, Pando MÁ, Giavedoni LD, Cahn P, Sued O, Salomon H, Gherardi MM.

J Virol. 2013 Jul;87(13):7445-62. doi: 10.1128/JVI.00865-13. Epub 2013 Apr 24.

12.

IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.

Rodríguez AM, Pascutti MF, Maeto C, Falivene J, Holgado MP, Turk G, Gherardi MM.

PLoS One. 2012;7(5):e37801. doi: 10.1371/journal.pone.0037801. Epub 2012 May 24.

13.

Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.

Falivene J, Del Médico Zajac MP, Pascutti MF, Rodríguez AM, Maeto C, Perdiguero B, Gómez CE, Esteban M, Calamante G, Gherardi MM.

PLoS One. 2012;7(2):e32220. doi: 10.1371/journal.pone.0032220. Epub 2012 Feb 22.

14.

Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.

Pascutti MF, Rodríguez AM, Falivene J, Giavedoni L, Drexler I, Gherardi MM.

J Virol. 2011 Jun;85(11):5532-45. doi: 10.1128/JVI.02267-10. Epub 2011 Mar 16.

15.

T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations.

Mónaco DC, Rodríguez AM, Pascutti MF, Carobene M, Falivene J, Gómez A, Maeto C, Turk G, Nájera JL, Esteban M, Gherardi MM.

PLoS One. 2011 Feb 18;6(2):e17185. doi: 10.1371/journal.pone.0017185.

16.

[Development of vaccines for HIV-1. Relevance of subtype-specific cellular immunity].

Rodríguez AM, Turk G, Pascutti MF, Falivene J, Gherardi MM.

Medicina (B Aires). 2010;70(6):543-54. Review. Spanish.

PMID:
21163746
17.

Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.

Rodríguez AM, Turk G, Pascutti MF, Ferrer F, Nájera JL, Mónaco D, Esteban M, Salomón H, Calamante G, Gherardi MM.

Virus Res. 2009 Dec;146(1-2):1-12. doi: 10.1016/j.virusres.2009.08.004. Epub 2009 Aug 26.

PMID:
19715734
18.

Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.

Turk G, Gherardi MM, Laufer N, Saracco M, Luzzi R, Cox JH, Cahn P, Salomon H.

J Virol. 2008 Mar;82(6):2853-66. doi: 10.1128/JVI.02260-07. Epub 2008 Jan 9.

19.

Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Nájera JL, Gómez CE, Domingo-Gil E, Gherardi MM, Esteban M.

J Virol. 2006 Jun;80(12):6033-47.

20.

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis.

Pérez-Jiménez E, Kochan G, Gherardi MM, Esteban M.

Microbes Infect. 2006 Mar;8(3):810-22. Epub 2006 Jan 13.

PMID:
16504562
21.

Recombinant poxviruses as mucosal vaccine vectors.

Gherardi MM, Esteban M.

J Gen Virol. 2005 Nov;86(Pt 11):2925-36. Review.

PMID:
16227213
23.
26.

Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens.

Gherardi MM, Ramírez JC, Esteban M.

Histol Histopathol. 2001 Apr;16(2):655-67. doi: 10.14670/HH-16.655. Review.

PMID:
11332721
27.

Salmonella enteritidis temperature-sensitive mutants protect mice against challenge with virulent Salmonella strains of different serotypes.

Gherardi MM, Gómez MI, García VE, Sordelli DO, Cerquetti MC.

FEMS Immunol Med Microbiol. 2000 Oct;29(2):81-8.

28.
29.
32.

Vaccination of chickens with a temperature-sensitive mutant of Salmonella enteritidis.

Cerquetti MC, Gherardi MM.

Vaccine. 2000 Jan 6;18(11-12):1140-5.

PMID:
10590336
33.

IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.

Gherardi MM, Ramirez JC, Rodríguez D, Rodríguez JR, Sano G, Zavala F, Esteban M.

J Immunol. 1999 Jun 1;162(11):6724-33.

34.

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants.

Gherardi MM, Esteban M.

Vaccine. 1999 Mar 5;17(9-10):1074-83.

PMID:
10195617
35.

Intramammary immunization with live-attenuated Staphylococcus aureus protects mice from experimental mastitis.

Gómez MI, García VE, Gherardi MM, Cerquetti MC, Sordelli DO.

FEMS Immunol Med Microbiol. 1998 Jan;20(1):21-7.

36.

Fts insertional mutant of Salmonella typhimurium.

Cerquetti MC, Brawer R, Gerdes CA, Gherardi MM, Sordelli DO.

FEMS Microbiol Lett. 1995 Oct 1;132(1-2):73-8.

PMID:
7590167
37.
38.

Local and systemic immunity against Streptococcus pneumoniae: humoral responses against a non-capsulated temperature-sensitive mutant.

García VE, Gherardi MM, Iglesias MF, Cerquetti MC, Sordelli DO.

FEMS Microbiol Lett. 1993 Apr 1;108(2):163-7.

PMID:
8486243
39.

Supplemental Content

Loading ...
Support Center